Publikation

Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand.

Wissenschaftlicher Artikel/Review - 01.06.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
European Pregnancy And Paediatric Infections Cohort Collaboration Eppicc, Lyons A, Thompson L, Chappell E, Ene L, Galli L, Goetghebuer T, Jourdain G, Noguera-Julian A, Kahlert C, Königs C, Kosalaraksa P, Lumbiganon P, Marczynska M, Marques L, Navarro M, Naver L, Okhonskaia L, Prata F, Puthanakit T, Ramos J, Samarina A, Thorne C, Voronin E, Turkova A, Giaquinto C, Judd A, Collins I. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand. Antivir Ther 2022; 27:13596535221092182.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Antivir Ther 2022; 27
Veröffentlichungsdatum
01.06.2022
eISSN (Online)
2040-2058
Seiten
13596535221092182
Kurzbeschreibung/Zielsetzung

Etravirine (ETR) is approved as a component of second or third-line antiretroviral treatment (ART) for children living with HIV. We assessed the outcomes of ETR-based ART in children in routine care in Europe and Thailand.